InvestorsHub Logo
Followers 364
Posts 113793
Boards Moderated 5
Alias Born 12/28/2000

Re: None

Wednesday, 07/20/2005 3:45:30 PM

Wednesday, July 20, 2005 3:45:30 PM

Post# of 72830
MTDX - lol They need to clarify that? It must have been the 100% line in their original pr:


Forward Split Clarification
Wednesday July 20, 3:28 pm ET

PHOENIX, July 20 /PRNewswire-FirstCall/ -- Motion DNA Corporation (Pink Sheets: MTDX.) Motion DNA Corporation has declared a 2:1 FORWARD SPLIT, to all shareholders of record of July 28, 2005, payable August 4, 2005. ALTHOUGH THIS IS A FREE ISSUANCE OF STOCK ON BEHALF OF THE COMPANY, THIS SHALL NOT IMPLY THE STOCK PRICE WILL REMAIN THE SAME.

About Motion DNA: Motion DNA Corporation provides diagnostic testing for medical professionals and sports organizations. Motion DNA's biomechanical analyses and detailed reports provide its customers and consumers with solutions for preventing injuries, identifying physical limitations, diagnosing preexisting injuries related to biomechanics, and improving physical performance levels. For additional information on the company, please visit the company website at www.motiondnacorp.com.

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications that may arise could prevent the prompt implementation of any strategically significant plan(s) outlined above. The company cautions that these forward-looking statements are further qualified by other factors. The company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.

For more information on Motion DNA Contact:
Investor Relations
Motion DNA Corporation
15023 N. 73rd Street
Scottsdale, Arizona 85260
1.877.425.7734 toll free
480.425.7734 phone
480.991.7736 fax


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.